期刊文献+

反义寡聚脱氧核苷酸对卵巢癌细胞系LPA受体抑制与对MMP-2和MMP-9的调控 被引量:2

Effect of antisense oligodeoxynucleotides on inhibition of LPA receptors and regulation of MMP-2 and MMP-9 in ovarian cancer cells
原文传递
导出
摘要 目的:研究溶血磷脂酸受体(LPA1、LPA2、LPA3)的反义寡核苷酸(ASODN)对卵巢癌细胞的抑制作用;探讨LPA对表达LPA受体ASODN的卵巢癌细胞株MMP2和MMP9表达及活性的影响。方法:将LPA1、LPA2和LPA3ASODN转入卵巢癌细胞系SKOV3和3AO,用RT-PCR和蛋白质印迹法鉴定转染细胞株的表达水平。通过检测细胞株生长、增殖变化观察转染细胞株的生物学特性,明胶酶谱检测分析LPA对表达LPA受体的ASODN的卵巢癌细胞株MMP-2、MMP-9表达及活性的影响。结果:LPA1、LPA2及LPA3ASODN均可有效的抑制LPA1基因、LPA2及LPA3蛋白质的表达。转染前后细胞株生长情况差异无统计学意义。明胶酶谱条带的灰度值分析显示,LPA诱导表达LPA2、LPA3ASODN的卵巢癌细胞株MMP-2、MMP-9活性降低,与对照组及正义组相比,差异有统计学意义,P<0.05。转染LPA1ASODN的卵巢癌细胞株MMP-2、MMP-9活性,与对照组及正义组相比,差异无统计学意义,P>0.05。结论:ASODN抑制LPA受体基因及蛋白质表达。在LPA诱导的MMPs活化过程中,LPA2及LPA3更有效,提示卵巢上皮性癌中LPA2和LPA3在LPA诱导的MMPs侵袭、转移过程中发挥主要作用。 OBJECTIVE:To evaluate the influence of LPA1,LPA2 and LPA3 antisense oligodeoxynucleotides(ASODN) on inhibition of human ovarian cancer 3AO and SKOV3 cells,and study the effects of lysophosphatidic acid (LPA) on MMP-2 and MMP-9 expressions and activities in ovarian cancer cells with transfected LPA receptors ASODN. METHODS:The LPA1,LPA2 and LPA3 antisense oligodeoxynucleotides (ASODN) were integrated into 3AO and SKOV3 cells lines. Transfection and expression were confirmed by the means of RT-PCR and Western blotting. The biological characteristics of the transfected cells were studied by the observation of their growth and proliferative periods. The effect of LPA on MMP-2 and MMP-9 protein expressions and activities in transfected ovarian cells was analyzed by gelatin zymography. RESULTS:The LPA1 gene,LPA2 and LPA3 protein expressions were decreased in ovarian cancer cells with LPA1,LPA2 and LPA3 ASODN transfection. The transfected cells growth characteristics were not different before and after the transfectation. The gelatin zymography confirmed that LPA-induced the activities and protein expressions of MMP-2 and MMP-9 decreased in the transfected cells with LPA2 and LPA3 receptors ASODN,compared with those in the control group and SODN group (P〈0.05). The activities and protein expressions of MMPs in LPA1 receptors ASODN cells did not decrease,compared with those in the control group and SODN group (P〉0.05). CONCLSUIONS:LPA receptors antisense oligodeoxynucleotides can inhibite the expressions of LPA receptors gene and protein. LPA2 and LPA3 were more efficient in LPA-induced MMPs activity. LPA2 and LPA3 play important roles in the process of LPA-induced MMP invasion and metastasis of ovarian carcer cells.
出处 《中华肿瘤防治杂志》 CAS 2010年第1期50-54,共5页 Chinese Journal of Cancer Prevention and Treatment
关键词 卵巢肿瘤 溶血磷脂酸 受体 基质金属蛋白酶类 ovarian neoplasms lysophosphatidic acid receptors matrix metalloproteinases
  • 相关文献

参考文献15

  • 1汪萍,吴小华,刘金,陈文雪,单保恩.卵巢上皮性肿瘤中溶血磷脂酸受体表达及其生物学意义[J].肿瘤,2006,26(3):289-292. 被引量:2
  • 2Wang P, Wu X, Chen W, et al. The lysophosphatidic acid (LPA) receptors their expression and significance in epithelial ovarian neoplasms[J]. Gynecol Oncol, 2007,104(3):714- 720. 被引量:1
  • 3汪萍,吴小华,陈文雪,赵喜庆.溶血磷脂酸对人卵巢癌细胞基质金属蛋白酶-2、9蛋白表达的影响[J].肿瘤,2006,26(9):819-822. 被引量:3
  • 4Simon M F, Daviaud D, Pradere J P, et al. Lysophosphatidic acid inhibits adipoeyte differentiation via lysophosphatidic acid 1 receptor-dependent down-regulation of peroxisome proliferator-activated receptor gamma[J]. J Biol Chem, 2005, 280(15) :14656- 14662. 被引量:1
  • 5Fang X, Yu S, Bast R C, et al. Mechanisms for lysophosphatid ic acid-induced cytokion production in ovarian cancer cells[J]. J Bio Chem, 2004, 279(10) :9651-9661. 被引量:1
  • 6Hama K, Aoki J, Fukaya M, et al. Lysophosphatidic acid and autotoxin stimulate cell motility of neoplastic and nonneoplastie cells through LPA1[J]. J Biol Chem, 2004, 279(17):17634-17639. 被引量:1
  • 7Lee Z, Swaby R F, Liang Y, et al. Lysophosphatidic acid is a major regulator of growth regulated oncogene alpha in ovarian cancer[J]. Cancer Res, 2006, 66(5) :2740-2748. 被引量:1
  • 8Chun J, Rosen H. Lysophospholipid receptors as potential drug targets in tissue transplantation and autoimmune diseases[J]. Curr Pharm Des, 2006, 12(2):161 -171. 被引量:1
  • 9Kelley G G, Kaproth-Joslin KA, Reks SE, et al. G protein-cou pied receptor agonists activate endogenous phospholipase Cepsilon and phospholipase C133 in a temporally distinct manner[J]. J Biol Chem, 2006, 281(5),2639-2648. 被引量:1
  • 10Ye X, Hama K, Contos J J, et al. LPA3-mediated lysophosphatidic acid signalling in embryo implantation and spacing[J]. Na ture, 2005, 435(7038):104-108. 被引量:1

二级参考文献26

  • 1XU Y, GAUDETTE D C, BPYNTON J D, et al. Characterization of an ovarion cancer activating in ascites from ovarion cancer patients[J]. Clin Cancer Res, 1995,1 :1223-1313. 被引量:1
  • 2SHIDA D, KITAYAMA J, YAMAGUCHI H, et al. Lysophosphatidic acid enhances the metastatic potential of human colon carcinoma DLD1 cells through LPA1 [J]. Cancer Res, 2003,63(7) : 1706-1711. 被引量:1
  • 3FISHMAN D A, LIU Y, SHAWN M, et al. Lysophosphatidic acid promotes matrix metalloproteinase (MMP) activation and MMP-dependent invasion in ovarion cancer cells [J]. Cancer Res ,2001,61(7) :3194-3199. 被引量:1
  • 4HU Y L, TEE M K, GOETZL E J, et al. Lysophosphatidie acidinduction of vascular endothelial growth factor expression inhuman ovarian cancer cells[J]. J Natl Cancer Inst, 2001,93762-768. 被引量:1
  • 5GORDON B M, WOUTER H M. The emerging role of lysophosphatidic acid in cancer[J]. Nature, 2003,3 : 582-591. 被引量:1
  • 6FANG X, YU S X, ROBERT C, et al. Meehanisms for Lysophosphatidic acid-induced cytokion production in ovarian cancer cells[J]. J Biol Chem ,2004,279(10) :9651-9661. 被引量:1
  • 7FURUI T,LAPUSHIN R,MAO M,et al. Overexpression of Edg-2/vzg 1 induces apoptosis and anoikis in ovarian cancer cells in a lysophosphatidic acid independent manner[J]. Clin Cancer Res, 1999,5 : 4308-4318. 被引量:1
  • 8HUANG MC,GRAELER MS,HANLAR G,et al. Lysophospholipid mediators of immunity and neoplasia[J]. Biochim Bio phys Acta,2002,1582(1-3),161-167. 被引量:1
  • 9YAMADA T,SATO K,KOMACH M,et al. Lysophosphatidic acid(LPA) in malignant ascites stimulates motility of humanpan creatic cancer cells through LPA:[J]. Biol Chem, 2004,279(8) :6595-6605. 被引量:1
  • 10SHIDA D, WATANABE T, AOKI J, et al. Aberrant expression of lysophosphatidic acid receptors in human colorectal cancer[J]. Lab Invest, 2004,1-11. 被引量:1

共引文献3

同被引文献31

  • 1陈亚楠,陶敏,涂福平,左云,段卫明,刘永标,宋宇.溶血磷脂酸及其受体在卵巢上皮癌中的表达及其临床意义[J].临床肿瘤学杂志,2007,12(4):264-266. 被引量:1
  • 2Xu Y, Gaudette DC, Boynton JD, et al. Characterization of an ovarian cancer activating factor in ascites from ovarian cancer patients[J]. Clin Cancer Res, 1995, 1(10): 1223-1232. 被引量:1
  • 3Mills GB, May C, Mcgill M, et al. A putative new growth factor in ascitic fluid from ovarian cancer patients: identification,characterization, and mechanism of action [J]. Cancer Res, 1988, 48(5) :1066-1071. 被引量:1
  • 4Xu Y, Shen ZZ, Donald W, et al. Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers [J]. J AMA, 1998, 280(8):719-723. 被引量:1
  • 5Jalink K, Eichholtz T, Postma FR, et al. Lysophosphatidic acid induces neuronal shape changes via a novel, receptor-mediated signaling pathway: similarity to thrombin action [J]. Cell Growth Differ, 1993, 4(4) :247-255. 被引量:1
  • 6van Corven EJ, Groenink A, Jalink K, et al. Lysophosphatid ate-induced cell proliferation: identification and dissection of sig naling pathways mediated by G proteins[J]. Cell, 1989, 59 (1) 45-54. 被引量:1
  • 7Weiner JA, Chun J. Schwann cell survival mediated by the signaling phospholipid lysophosphatidic acid[J]. Proc Natl Acad Sci USA, 1999,96(9):5233-5238. 被引量:1
  • 8Wu WT, Chen CN, Lin CI, et al. Lysophospholipids enhance matrix metalloproteinase-2 expression in human endothelial cells [J]. Endocrinology, 2005, 146(8) :3387-3400. 被引量:1
  • 9Hu YL, Tee MK, Goetzl EJ, et al. Lysophosphatidic acid induction of vascular endothelial growth factor expression in hu- man ovarian cancer cells[J]. J Natl Cancer Inst, 2001, 93(10) : 762-768. 被引量:1
  • 10Schwartz BM, Hong G, Morrison BH, et al. Lysophospholipids increase interleukin-8 expression in ovarian cancer cells[J]. Gynecol Oncol, 2001, 81(2): 291-300. 被引量:1

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部